254 related articles for article (PubMed ID: 11250007)
21. Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo.
Najm FJ; Madhavan M; Zaremba A; Shick E; Karl RT; Factor DC; Miller TE; Nevin ZS; Kantor C; Sargent A; Quick KL; Schlatzer DM; Tang H; Papoian R; Brimacombe KR; Shen M; Boxer MB; Jadhav A; Robinson AP; Podojil JR; Miller SD; Miller RH; Tesar PJ
Nature; 2015 Jun; 522(7555):216-20. PubMed ID: 25896324
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-1beta promotes oligodendrocyte death through glutamate excitotoxicity.
Takahashi JL; Giuliani F; Power C; Imai Y; Yong VW
Ann Neurol; 2003 May; 53(5):588-95. PubMed ID: 12730992
[TBL] [Abstract][Full Text] [Related]
23. Neuronal activity regulates remyelination via glutamate signalling to oligodendrocyte progenitors.
Gautier HO; Evans KA; Volbracht K; James R; Sitnikov S; Lundgaard I; James F; Lao-Peregrin C; Reynolds R; Franklin RJ; Káradóttir RT
Nat Commun; 2015 Oct; 6():8518. PubMed ID: 26439639
[TBL] [Abstract][Full Text] [Related]
24. System xc- and glutamate transporter inhibition mediates microglial toxicity to oligodendrocytes.
Domercq M; Sánchez-Gómez MV; Sherwin C; Etxebarria E; Fern R; Matute C
J Immunol; 2007 May; 178(10):6549-56. PubMed ID: 17475885
[TBL] [Abstract][Full Text] [Related]
25. Increased expression of cystine/glutamate antiporter in multiple sclerosis.
Pampliega O; Domercq M; Soria FN; Villoslada P; Rodríguez-Antigüedad A; Matute C
J Neuroinflammation; 2011 Jun; 8():63. PubMed ID: 21639880
[TBL] [Abstract][Full Text] [Related]
26. Differential oxidative stress in oligodendrocytes and neurons after excitotoxic insults and protection by natural polyphenols.
Ibarretxe G; Sánchez-Gómez MV; Campos-Esparza MR; Alberdi E; Matute C
Glia; 2006 Jan; 53(2):201-11. PubMed ID: 16206167
[TBL] [Abstract][Full Text] [Related]
27. Glutamate uptake by oligodendrocytes: Implications for excitotoxicity in multiple sclerosis.
Pitt D; Nagelmeier IE; Wilson HC; Raine CS
Neurology; 2003 Oct; 61(8):1113-20. PubMed ID: 14581674
[TBL] [Abstract][Full Text] [Related]
28. Glutamate, T cells and multiple sclerosis.
Levite M
J Neural Transm (Vienna); 2017 Jul; 124(7):775-798. PubMed ID: 28236206
[TBL] [Abstract][Full Text] [Related]
29. Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate.
Follett PL; Deng W; Dai W; Talos DM; Massillon LJ; Rosenberg PA; Volpe JJ; Jensen FE
J Neurosci; 2004 May; 24(18):4412-20. PubMed ID: 15128855
[TBL] [Abstract][Full Text] [Related]
30. AMPA/kainate receptor activation in murine oligodendrocyte precursor cells leads to activation of a cation conductance, calcium influx and blockade of delayed rectifying K+ channels.
Borges K; Ohlemeyer C; Trotter J; Kettenmann H
Neuroscience; 1994 Nov; 63(1):135-49. PubMed ID: 7898644
[TBL] [Abstract][Full Text] [Related]
31. Reduction of AMPA receptor activity on mature oligodendrocytes attenuates loss of myelinated axons in autoimmune neuroinflammation.
Evonuk KS; Doyle RE; Moseley CE; Thornell IM; Adler K; Bingaman AM; Bevensee MO; Weaver CT; Min B; DeSilva TM
Sci Adv; 2020 Jan; 6(2):eaax5936. PubMed ID: 31934627
[TBL] [Abstract][Full Text] [Related]
32. On how altered glutamate homeostasis may contribute to demyelinating diseases of the CNS.
Matute C; Domercq M; Fogarty DJ; Pascual de Zulueta M; Sánchez-Gómez MV
Adv Exp Med Biol; 1999; 468():97-107. PubMed ID: 10635022
[TBL] [Abstract][Full Text] [Related]
33. [Oligodendroglial exocytosis y demyelination in the optic nerve].
Pérez-Cerdá F; Matute C
Arch Soc Esp Oftalmol; 2000; 75(5):301-4. PubMed ID: 11151164
[No Abstract] [Full Text] [Related]
34. AMPA-mediated excitotoxicity in oligodendrocytes: role for Na(+)-K(+)-Cl(-) co-transport and reversal of Na(+)/Ca(2+) exchanger.
Chen H; Kintner DB; Jones M; Matsuda T; Baba A; Kiedrowski L; Sun D
J Neurochem; 2007 Sep; 102(6):1783-1795. PubMed ID: 17490438
[TBL] [Abstract][Full Text] [Related]
35. Excitatory amino acid induced oligodendrocyte cell death in vitro: receptor-dependent and -independent mechanisms.
Rosin C; Bates TE; Skaper SD
J Neurochem; 2004 Sep; 90(5):1173-85. PubMed ID: 15312172
[TBL] [Abstract][Full Text] [Related]
36. Autoimmune encephalomyelitis ameliorated by AMPA antagonists.
Smith T; Groom A; Zhu B; Turski L
Nat Med; 2000 Jan; 6(1):62-6. PubMed ID: 10613825
[TBL] [Abstract][Full Text] [Related]
37. Neurotrophin-3 (NT-3) diminishes susceptibility of the oligodendroglial lineage to AMPA glutamate receptor-mediated excitotoxicity.
Kavanaugh B; Beesley J; Itoh T; Itoh A; Grinspan J; Pleasure D
J Neurosci Res; 2000 Jun; 60(6):725-32. PubMed ID: 10861784
[TBL] [Abstract][Full Text] [Related]
38. Excitotoxic mechanisms of ischemic injury in myelinated white matter.
Tekkök SB; Ye Z; Ransom BR
J Cereb Blood Flow Metab; 2007 Sep; 27(9):1540-52. PubMed ID: 17299453
[TBL] [Abstract][Full Text] [Related]
39. Multiple sclerosis and glutamate.
Groom AJ; Smith T; Turski L
Ann N Y Acad Sci; 2003 May; 993():229-75; discussion 287-8. PubMed ID: 12853317
[TBL] [Abstract][Full Text] [Related]
40. Excitotoxic damage to white matter.
Matute C; Alberdi E; Domercq M; Sánchez-Gómez MV; Pérez-Samartín A; Rodríguez-Antigüedad A; Pérez-Cerdá F
J Anat; 2007 Jun; 210(6):693-702. PubMed ID: 17504270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
